Multiple Sclerosis Highlights From ECTRIMS 2024

Summary: Dr. Patricia Coyle shared exciting news about Multiple Sclerosis (MS) from a big 2024 medical meeting. First, treating kids with MS early helps them stay healthier into their 20s. Second, a new drug called frexalimab safely lowers MS activity. Third, women with MS who take medicine can still have safe pregnancies, though birth rates might be slightly lower. Finally, a drug called tolebrutinib slowed down MS disability by 31%.

For more details, see rssapp-mdedge-com-hospitalist at mdedge.com/neurology/article/271121/conference-recap/multiple-sclerosis-highlights-ectrims-2024 (opens in new tab)

Tags

Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Disease
Sclerosis
Protein-Tyrosine Kinases
Agammaglobulinaemia Tyrosine Kinase